
2020 ISB Virtual Microbiome Series
The inaugural ISB Virtual Microbiome Series highlighted recent in silico, in vitro, and in vivo advances toward engineering the gut microbiome to resolve complex diseases.
Filter
Sort
The inaugural ISB Virtual Microbiome Series highlighted recent in silico, in vitro, and in vivo advances toward engineering the gut microbiome to resolve complex diseases.
ISB researchers examined the associations between the gut microbiomes of about 3,400 people and roughly 150 host characteristics. The team looked at diet, medication use, clinical blood markers, and other lifestyle and clinical factors, and found evidence that variations of the gut microbiome are associated with health and disease.
Everybody pees and poops. What if there was a way to use the byproducts of our everyday bodily functions to understand the general health of a population? That is exactly what MIT’s Dr. Eric Alm is pursuing. In an ISB-Town Hall Seattle live stream, Alm discussed the promise of this novel form of public health tracking.
James Johnson joins the lab as a bioengineering PhD student at the University of Washington (UW). James earned his BS in Chemical Engineering from Texas A&M University.
Nick Bohmann joins the lab as a Ph.D. student from the Molecular Engineering and Sciences program at UW. Nick graduated from Virginia Tech in 2019 with B.S. in Biological Systems Engineering.
How can we harness successional ecology to quickly repair antibiotic-damaged gut microbiota? ISB Assistant Professor Dr. Sean Gibbons wrote this commentary for the journal Nature Microbiology detailing recent research that answers that question. Click the link to read the story (link will open as a new window). Illustration by Allison Kudla, PhD / ISB.